|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
ACCESS FULL STORIES
iBio, GE partner to work on plant-based production tech
iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology...
Read
Bend receives patent for making spray-dried drug dispersions using pressure nozzles
US formulation services provider Bend Research has received a new patent for the process of producing spray-dried solid amorphous dispersions of drugs using single-fluid pressure nozzles...
Read
BI opens 'Centre of Competence' opens as part of a €100m China plan
Boehringer Ingelheim has opened its 'Centre of Competence' (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China...
Read
Ranbaxy opens $30m SA plant to meet govt call for India trade boost
Ranbaxy is latest firm targeting South African growth with a new £30m (€24m) Johannesburg tablet and capsule manufacturing plant...
Read
NanGenex adds bench-top, pilot nano API production tech
NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients...
Read
News in brief Plant-expressed vaccine site buying Xcellerex bioreactors
Xcellerex is providing XDR GMP single-use production bioreactors to the plant-expressed vaccine consortium behind Project GreenVax...
Read
|
|||||||||||||||||||||||||||||||||||||||||||||
| All News Headlines for: September | August | July | |||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
RELATED INDUSTRY NEWS
Accenture & ICRI partner for Indian clinical research training
Accenture and ICRI have partnered to jointly develop a pharmacovigilance and clinical research programme for the Indian market...
Read
Quintiles lands CF drug commercialisation contract
Quintiles will help Australian drugmaker Pharmaxis launch its cystic fibrosis treatment Bronchitol in Europe under a contract announced yesterday...
Read
Asuragen adds KRAS, BRAF testing for personalised med
Asuragen is introducing KRAS and BRAF mutational testing services to support development of personalised colorectal cancer treatments...
Read
TiGenix to spin-out drug discovery activities as Arcarios
TiGenix to spin-out its discovery and development business as new small-molecule focused industry-academia consortium Arcarios...
Read
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
PREVIOUS HEADLINES
Industry view Regulatory expert insight: Regulatory information management
Tracking "non-content" metadata is an important part of any pharmaceutical submission, yet many drugmakers fail to take an integrated approach to the task according to regulatory expert Kate Wilber...
Listen
RecipharmCobra gets patents for yield-boosting plasmid tech
RecipharmCobra Biologics has received US and EU patent protection for an antibiotic resistance gene-free plasmid maintenance technology it claims can boost biomanufacturing yields...
Read
Prosonix launches ultrasound-assisted co-crystal service
Prosonix has launched a co-crytsallisation service for the production of APIs for inhalable drugs and oral medicines...
Read
US gov support needed for overhaul of vacc production
Cell culture, LAIV vaccines and recombinant DNA technology should be supported by the US government as part of a long-term overhaul of pandemic response capabilities, according to PCAST...
Read
Genzyme rejects Sanofi's $18.5bn bid; IPT looks at biotech's turbulent 18-months
Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing "to establish a basis for engagement."..
Read
News in brief SK opts for Xcellerex' tech for vac production
SK Chemicals hopes Xcellerex' manufacturing technology will boost vaccine production business...
Read
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
To continue to receive this newsletter in your inbox, please add newsletter@in-pharmatechnologist.com to your address book |
|||||||||||||||||||||||||||||||||||||||||||||
|
Update preferences |
Change your email address |
Unsubscribe
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
|||||||||||||||||||||||||||||||||||||||||||||
|
© 2010 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
|||||||||||||||||||||||||||||||||||||||||||||
|